STAT July 6, 2020
Erin Riglin

The analysis for this story was based on data from clinicaltrials.gov, a public database that includes records of registered studies from around the world.

The website is used by a general audience, including patients, researchers, and trial administrators, and searches on a query like “Covid-19” produce results that may not relate directly to the disease — for instance, a study about an unrelated condition that mentions Covid-19 in passing in the description of the trial or in an auxiliary field in the database.

In order to mitigate the risk of including such results, a more detailed analysis was conducted on the complete dataset of nearly 350,000 current and historical records. That analysis helped weed out studies tangentially related to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
23andMe: What If …
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article